Reid G. Adler

Insider Reports History

Entity: Individual
Location: C/O Vistagen Therapeutics, Inc., 343 Allerton Ave., South San Francisco, CA
Signature: /s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reid G. Adler:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Vistagen Therapeutics, Inc.	CHF CORP DEVEL OFF, GEN COUNS	Common Stock	16.5K	$48.8K	$2.96	Jun 28, 2024	Direct
Vistagen Therapeutics, Inc.	CHF CORP DEVEL OFF, GEN COUNS	Stock Option (Right to Buy)	170K			Jun 24, 2024	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Reid G. Adler

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
VTGN	Vistagen Therapeutics, Inc.	Jun 28, 2024	1	$14.4K	4	Jul 2, 2024	CHF CORP DEVEL OFF, GEN COUNS
VTGN	Vistagen Therapeutics, Inc.	Jun 24, 2024	1	$0	4	Jun 26, 2024	CHF CORP DEVEL OFF, GEN COUNS
VTGN	Vistagen Therapeutics, Inc.	Dec 29, 2023	1	$287	4	Jan 3, 2024	CHF CORP DEVEL OFF, GEN COUNS
VTGN	Vistagen Therapeutics, Inc.	Jun 30, 2023	1	$265	4	Jul 5, 2023	CHIEF LEGAL OFFICER
VTGN	VistaGen Therapeutics, Inc.	Aug 17, 2022	1	$50.9K	4	Aug 19, 2022	CHIEF LEGAL OFFICER
VTGN	VistaGen Therapeutics, Inc.	May 2, 2022	1	$0	4	May 3, 2022	CHIEF LEGAL OFFICER
VTGN	VistaGen Therapeutics, Inc.	May 2, 2022	0	$0	3	May 3, 2022	CHIEF LEGAL OFFICER